Stockscreener 앱 받기
1.51
4.14%
0.06
시간 외 거래:
1.51
Filana Therapeutics Inc 주식(FLNA)의 최신 뉴스
MSN Money - MSN
[ARS] FILANA THERAPEUTICS, INC. SEC Filing - Stock Titan
Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan
Filana Therapeutics (FLNA) director O’Donnell to leave board after 2026 meeting - Stock Titan
FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart - MEXC
Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20Continuation Pattern - Xã Châu Thành
FLNA Filana Therapeutics reports narrower Q3 2025 loss than expected, shares rise 1.45 percent in today’s session.Hot Market Picks - Newser
symbol__ Stock Quote Price and Forecast - CNN
Is Filana Therapeutics (FLNA) stock a buy today (Bearish Momentum) 2026-04-18Stock Trading Network - Newser
FLNA | Filana Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
FLNA Stock Price, News & Analysis - Stock Titan
Filana Therapeutics publishes simufilam preclinical data - TipRanks
Filana Therapeutics Publishes Study Highlighting Simufilam's Potential to Attenuate Seizure Progression in Tuberous Sclerosis Complex Model - Quiver Quantitative
In severe epilepsy mouse model, Filana drug slowed seizure worsening - Stock Titan
FLNA Options Chain — NASDAQ:FLNA - TradingView
FLNA Options Volatility — NASDAQ:FLNA - TradingView
Filana Therapeutics Inc Live Share Prices and Trades. FLNA.US Live Streaming Share Prices. - London South East
Filana Therapeutics Inc Share Price (FLNA.US) - London South East
What is the valuation of Filana Therapeutics (FLNA) Stock | Price at $1.70, Up 1.50%Pre Earnings - Newser
Is Filana Therapeutics (FLNA) Stock Near Resistance | Price at $1.68, Down 2.89%Elite Alerts - Newser
Issuance/retirement of stock (net) of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Should I Buy - Intellectia AI
Filana Therapeutics, Inc. (FLNA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Capital expenditures of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Free cash flow per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView — Track All Markets
Price to book ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc. Balance Sheet – NASDAQ:FLNA - TradingView
Long term debt to total equity ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
EBIT of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Number of shareholders of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | FLNA * | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | PX91 | US14817C1071 - marketscreener.com
Changes in working capital of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | FLNA | US14817C1071 - marketscreener.com
Non-controlling/minority interest of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Taxes of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Technical Analysis & Stock Price Forecast - Intellectia AI
Filana Therapeutics (FLNA) Stock Analysis Report | Financials & Insights - Benzinga
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PX91 | US14817C1071 - marketscreener.com
Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Filana Therapeutics Inc (FLNA-Q) Profile - The Globe and Mail
Filana Therapeutics Inc FLNA-Q Earnings - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Insider Trade Summaries - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Stock Price and News - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Statistics - The Globe and Mail
Net income before discontinued operations of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total liabilities & shareholders' equities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SAVA * | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc. Statistics – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Financial Data Forecasts Estimates and Expectations | SAVA * | US14817C1071 - marketscreener.com
2.45%
자본화:
|
볼륨(24시간):